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Background: Poor ovarian response and retrieval of no oocytes following ovarian stimulation for in vitro fertilization
(IVF) is a challenging problem for both the patient and the clinician.
Findings: Recent evidence indicates that folliculogenesis occurs in a wave-like fashion indicating that there are
multiple follicular recruitment waves in the same menstrual cycle. This relatively new scientific concept provides
new opportunities for the utilization of ovarian stimulation in women with poor ovarian response. This
communication reports on the social and scientific rationale for the use of luteal phase ovarian stimulation
following oocyte retrieval in the same cycle (also called double stimulation).
Conclusions: Data to date showed that double ovarian stimulation in poor responders provides shorter time for
retrieving mature oocytes with the potential formation of good quality embryos, and thus healthy pregnancies.
Keywords: Luteal phase stimulation, Double ovarian stimulation, Poor ovarian response, Diminished ovarian reserve,
IVF
Introduction
Poor ovarian response after ovarian stimulation for in vitro
fertilization (IVF) is a challenge for the patients and their
clinicians. Currently, ovarian stimulation in women with di-
minished ovarian reserve (DOR) has been individualized
due to the development of a variety of ovarian stimulation
protocols [1, 2]. Many studies have evaluated the use of
various ovarian stimulation regimens to improve the out-
come of poor responders undergoing IVF treatment; some
of these protocols involve minimal/mild ovarian stimulation
[3]. Additionally, patients with poor prognosis have high
cancellation rates, along with lower pregnancy and live
birth rates. These relatively high cancellation rates are lead-
ing clinicians and researchers to question whether IVF with
conventional “follicular phase” ovarian stimulation has
alternative approaches in the DOR population [4].
Recent evidence indicates that folliculogenesis occurs in
a wave-like fashion [5]. Thus, in the same menstrual cycle,
there are multiple follicular recruitment waves [5]. This
fact challenges the traditional theory that a single cohort
of antral follicles only develop during the follicular phase
of the menstrual cycle [6]. It also provides other new op-
portunities for clinicians to utilize ovarian stimulation es-
pecially in women with DOR [6]. This manuscript reports
on the social and scientific rationale for the use of luteal
phase ovarian stimulation following oocyte retrieval, in
the same cycle (also called double ovarian stimulation)
when follicular phase ovarian stimulation was already
undergone. It also addresses special situations where luteal
phase stimulation could represent an alternative for pa-
tients with DOR when no oocytes were retrieved in the
conventional “follicular phase” ovarian stimulation IVF.
Findings
Social and Scientific basis for luteal phase ovarian
stimulation
It is not uncommon to have no oocytes retrieved in
women with DOR undergoing IVF especially when there
is very little follicular growth [7]. In these situations, no
oocytes are usually retrieved from apparently normally
growing ovarian follicles with normal estradiol concen-
trations despite meticulous repeated follicular aspiration
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and flushing [8]. Reasons for this include poor ovarian
response, errors in human chorionic gonadotrophin
(hCG) administration/timing for final oocyte maturation,
underlying ovarian dysfunction, or premature ovulation
[9–11]. In spite of these reasons, obtaining no oocytes
following oocyte retrieval represents a tremendous stress
for the patient. Luteal phase stimulation could poten-
tially alleviate some of this stress since the patients do
not have to wait for another menstrual cycle before
undergoing ovarian stimulation.
Folliculogenesis is an ongoing process in which multiple
follicles are in the process of development [12, 13]. The
traditional concept of folliculogenesis supports the recruit-
ment of various antral follicles in each ovary from the
“late luteal phase” of the preceding menstrual cycle to the
following follicular phase [12]. Interestingly, there is in-
creasing evidence to indicate that multiple waves of antral
follicles develop during the same woman’s menstrual cycle
challenging the concept of single recruitment episode dur-
ing the follicular phase [12, 14].
Three theories of antral follicle recruitment have been
suggested [12]. The first theory of “continuous recruit-
ment” suggests that small antral follicles grow and regress
constantly throughout the inter-ovulatory (between two
ovulatory events) interval and the dominant ovulatory fol-
licle is selected by chance from the pool following luteal
regression [12]. The second theory of a “single recruit-
ment episode” suggests that an ovulatory follicle is se-
lected from a single follicular cohort that emerges
following luteal regression [12]. The third “wave theory”
of follicle recruitment suggests that two or more cohorts
of antral follicles are recruited during the same ovarian
cycle. The dominant follicle that develops in the final wave
of the inter-ovulatory interval ovulates while preceding
waves are anovulatory [12]. The “wave theory” of follicle
recruitment is the basis of the luteal phase ovarian
stimulation protocol. Whether synchronization of the
emergence of follicular waves with ovarian stimulation
produces more competent oocytes and healthier embryos
and whether it enhances the efficiency of assisted repro-
ductive technology in women with DOR remains to be
determined [15].
Luteal phase ovarian stimulation protocol and review of
pertinent studies
A typical protocol of luteal phase ovarian stimulation
starts 2–7 days following oocyte retrieval during the
same menstrual cycle. Following oocyte retrieval, a sec-
ond ovarian stimulation is usually started with low dose
gonadotropins (75–150 IU/day) and either clomiphene
citrate (25–100 mg/day) or letrozole (2.5–5 mg/day) when
the lead follicle measures less than 13 mm [16]. After
5 days of stimulation, ultrasound and blood hormone
monitoring is resumed as usual. Human chorionic gonad-
otropins (5000 IU) or GnRH agonist (0.1 mg) is then used
for oocyte maturation when the lead follicle becomes lar-
ger than 18 mm (Fig. 1). Because clomiphene citrate could
cause a thin endometrial lining [17, 18], and because the
endometrium is out of phase following luteal phase stimu-
lation, embryo freezing is usually recommended followed
by a frozen embryo transfer in a subsequent cycle [19].
A randomized, controlled study investigated the benefit
of luteal phase ovarian stimulation in patients who previ-
ously had a suboptimal ovarian stimulation cycle [20]. In
that study, 40 patients with poor ovarian response, defined
as having 3–6 retrieved oocytes in their previous cycle,
were included. Compared to women who had recombin-
ant human gonadotropins in the early follicular phase,
women who had luteal phase stimulation had similar
number of oocytes retrieved [20]. Although, that
study indicated that poor responders do not benefit
from commencing recombinant human FSH therapy
in the luteal phase, it demonstrated that luteal phase
stimulation could produce a reasonable number of
Fig. 1 Double ovarian stimulation protocol: both follicular and luteal phase ovarian stimulation in the same cycle. GnRHa, gonadotropin releasing
hormone agonist; hCG, human chorionic gonadotropin; FSH, follicle-stimulating hormone; LH, luteinizing hormone
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oocytes thus representing an alternative to follicular
phase stimulation in poor responders. However, that
study did not evaluate double ovarian stimulation in
the same menstrual cycle and it did not assess clinical
or live birth rates.
Another randomized, open-label pilot trial (total n = 18)
investigated whether luteal phase initiation of gonadotro-
pins would improve oocyte yield compared with follicular
phase administration in women (age range 20–42) with
poor ovarian response [21]. In that trial, poor ovarian re-
sponse in a previous cycle was defined as either less than
5 follicles on day of HCG administration, or less than 5
oocytes retrieved, or previous cancelled IVF cycle. Gonad-
otropins were administered during either the follicular
phase (n = 9) or the mid-luteal phase of the preceding
menstrual cycle (n = 9). The number of oocytes retrieved
was similar regardless of the stimulation phase. Other
endpoints including follicular growth, serum estradiol
levels, and pregnancy and live birth rates did not differ be-
tween the luteal or follicular phase stimulation [21]. That
study indicated that luteal phase initiation of gonado-
tropins is a safe and potential alternative protocol in
poor responders when other protocols have failed.
A recent pilot study evaluated the efficacy of double
ovarian stimulation during the follicular and luteal phases
in women (n = 38, mean age = 36) with poor ovarian re-
sponse undergoing mild ovarian stimulation IVF [16].
After the first oocyte retrieval, gonadotropins and
letrozole were co-administrated to stimulate follicular
development. Oocyte retrieval was carried out a second
time when dominant follicles had matured following a
GnRH agonist trigger. The number of oocytes retrieved
was 1.7 ± 1.0 in the first retrieval (follicular phase ovarian
stimulation) versus 3.5 ± 3.2 in the second retrieval (luteal
phase ovarian stimulation) (p = 0.001). Additionally, the
number of mature (metaphase II) oocytes was 1.4 ± 1.0
versus 2.7 ± 2.7 (p = 0.008) in the first and second oocyte
retrievals respectively [16]. From the double stimulation,
167 oocytes were collected and 26 out of 38 (68.4 %)
succeeded in producing 1–6 viable embryos cryopre-
served for later transfer. Twenty-one women under-
went 23 cryopreserved embryo transfers, resulting in
13 clinical pregnancies. This study underscores the
usefulness of luteal phase stimulation in assisted re-
productive technology.
A recent case report of a patient (aged 41) who had se-
vere DOR as manifested by antral follicle count of 2 also
showed success with double ovarian stimulation [16]. That
patient underwent minimal ovarian stimulation IVF
protocol (using clomiphene citrate with low dose gonado-
tropins). One mature oocyte leading to a good embryo
was successfully obtained through luteal phase ovarian
stimulation following failure to retrieve any oocytes by
minimal ovarian stimulation in the conventional follicular
phase ovarian stimulation earlier in the same menstrual
cycle [16]. This case reinforces the fact that luteal phase
stimulation represents a clinically valuable alternative
when no oocytes were retrieved following IVF with
follicular phase ovarian stimulation.
Conclusion
Double ovarian stimulation (follicular and luteal phases) in
the same menstrual cycle could provide an opportunity to
retrieve more oocytes, potentially producing a pregnancy in
poor responders in a shorter period of time. Although lu-
teal phase ovarian stimulation does not seem to be better
than follicular phase ovarian stimulation, it could produce a
positive (good embryo) outcome in women with DOR
when no oocytes were retrieved in the same conventional
IVF cycle. This, without doubt, alleviates some of the stress
that poor responders have following a “no egg” results.
Additionally, the resulting embryos from luteal phase ovar-
ian stimulation protocols could have similar developmental
potential and could produce clinically acceptable pregnancy
rates when compared to embryos produced by follicular
phase ovarian stimulation. Double stimulation thus repre-
sents a promising approach for patients with poor ovarian
response especially when conventional IVF protocols have
failed or when time is of the essence. It is unfortunate that
studies to date included small sample sizes. Large cohort
studies/randomized clinical trials with live-birth rates as
outcomes are needed to better elucidate the benefit of luteal
phase (and double) ovarian stimulation in the DOR
population.
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